Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

MedImmune seeks Canadian approval for RespiGam

July 5, 1996

BMS describes antifungal effects of ascosteroside

July 5, 1996

Amphocil safe, effective in BMT patients

July 5, 1996

Atovaquone/proguanil combination shows efficiency and safety

June 28, 1996

Lidak's Lidakol undergoes phase III trials

June 28, 1996

CSL to distribute OraVax's HNK20

June 28, 1996

Antifungal agents revealed by Merck & Co.

June 28, 1996

Antibacterial agents revealed by Wakunaga

June 28, 1996

Pharmacia & Upjohn reveal antimicrobial phenyloxazolidinones

June 28, 1996

Zeneca's Merrem receives FDA clearance

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...